09.05.2013 14:35 Uhr, Quelle: Presseportal

First Clinical Experiences With Fycompa® (perampanel) Show "Clear Therapeutic Benefit"

Eisai Europe Limited: Hatfield, England (ots/PRNewswire) - New data on early real life experience show perampanel is effective and well tolerated in patients with difficult-to-treat partial epilepsy The antiepileptic drug (AED) Fycompa (perampanel), shows a clear

Weiterlesen bei Presseportal

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz